The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Hung, Pei Fang ^a   Hong, Tse Ming ^b,c   Hsu, Yi Chiung ^d   Chen, Hsuan Yu ^d   Chang, Yih Leong ^c   Wu, Chen Tu ^c   Chang, Gee Chen ^e   Jou, Yuh Shan ^f   Pan, Szu Hua ^c   Yang, Pan Chyr ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

KINESIN; MOLECULAR MOTOR; PROTEIN KIF14; UNCLASSIFIED DRUG; CADHERIN; CD146 ANTIGEN; COLLAGEN TYPE 4; KIF14 PROTEIN, HUMAN; LAMININ; MCAM PROTEIN, HUMAN; ONCOPROTEIN; OSTEOBLAST CADHERIN; PROTEIN BINDING; SMALL INTERFERING RNA;

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL ANCHORAGE; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR VOLUME; TUMOR XENOGRAFT; ADENOCARCINOMA; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHUS; CELL ADHESION; CELL MOTION; CYTOLOGY; DRUG SCREENING; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; MOUSE; PATHOLOGY; PROGNOSIS; SCID MOUSE; SURVIVAL;

ADENOCARCINOMA; AGED; ANIMALS; ANTIGENS, CD146; BRONCHI; CADHERINS; CELL ADHESION; CELL MOVEMENT; COLLAGEN TYPE IV; COMPARATIVE GENOMIC HYBRIDIZATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINESIN; LAMININ; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM METASTASIS; ONCOGENE PROTEINS; PROGNOSIS; PROTEIN BINDING; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84876551334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061664     Document Type: Article

References (63)

1. Lipka E, Muller S, (2012) Potential roles for Kinesins at the cortical division site. Front Plant Sci 3: 158.
2. van den Berg R, Hoogenraad CC, (2012) Molecular motors in cargo trafficking and synapse assembly. Adv Exp Med Biol 970: 173-196.
3. Miki H, Setou M, Kaneshiro K, Hirokawa N, (2001) All kinesin superfamily protein, KIF, genes in mouse and human. Proc Natl Acad Sci U S A 98: 7004-7011.
4. Zhu C, Zhao J, Bibikova M, Leverson JD, Bossy-Wetzel E, et al. (2005) Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Mol Biol Cell 16: 3187-3199.
5. Molina I, Baars S, Brill JA, Hales KG, Fuller MT, et al. (1997) A chromatin-associated kinesin-related protein required for normal mitotic chromosome segregation in Drosophila. J Cell Biol 139: 1361-1371.
6. Ohkura H, Torok T, Tick G, Hoheisel J, Kiss I, et al. (1997) Mutation of a gene for a Drosophila kinesin-like protein, Klp38B, leads to failure of cytokinesis. J Cell Sci 110 (Pt 8): 945-954.
7. Gruneberg U, Neef R, Li X, Chan EH, Chalamalasetty RB, et al. (2006) KIF14 and citron kinase act together to promote efficient cytokinesis. J Cell Biol 172: 363-372.
8. Carleton M, Mao M, Biery M, Warrener P, Kim S, et al. (2006) RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure. Mol Cell Biol 26: 3853-3863.
9. Sagona AP, Stenmark H, (2010) Cytokinesis and cancer. FEBS Lett 584: 2652-2661.
10. Storchova Z, Pellman D, (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5: 45-54.
11. Ganem NJ, Storchova Z, Pellman D, (2007) Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17: 157-162.
12. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, et al. (2001) Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun 1: 4.
13. Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Cerhan J, et al. (2011) Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer. Breast Cancer Res Treat 129: 617-622.
14. Chen D, Pajovic S, Duckett A, Brown VD, Squire JA, et al. (2002) Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN. Cancer Res 62: 967-971.
15. Taniuchi K, Nakagawa H, Nakamura T, Eguchi H, Ohigashi H, et al. (2005) Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Res 65: 105-112.
16. Haruki T, Maeta Y, Nakamura S, Sawata T, Shimizu T, et al. (2010) Advanced cancer with situs inversus totalis associated with KIF3 complex deficiency: report of two cases. Surg Today 40: 162-166.
17. Gao J, Sai N, Wang C, Sheng X, Shao Q, et al. (2011) Overexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivo. Tumour Biol 32: 53-61.
18. Liu Z, Ling K, Wu X, Cao J, Liu B, et al. (2009) Reduced expression of cenp-e in human hepatocellular carcinoma. J Exp Clin Cancer Res 28: 156.
19. Yanagawa T, Watanabe H, Takeuchi T, Fujimoto S, Kurihara H, et al. (2004) Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta. Lab Invest 84: 513-522.
20. Mazumdar M, Lee JH, Sengupta K, Ried T, Rane S, et al. (2006) Tumor formation via loss of a molecular motor protein. Curr Biol 16: 1559-1564.
21. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, et al. (2007) Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 46: 373-384.
22. Taniwaki M, Takano A, Ishikawa N, Yasui W, Inai K, et al. (2007) Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Clin Cancer Res 13: 6624-6631.
23. Yu Y, Feng YM, (2010) The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer 116: 5150-5160.
24. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130.
25. Hoffman PC, Mauer AM, Vokes EE, (2000) Lung cancer. Lancet 355: 479-485.
26. Takeuchi K, Choi YL, Togashi Y, Soda M, Hatano S, et al. (2009) KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res 15: 3143-3149.
27. Ju YS, Lee WC, Shin JY, Lee S, Bleazard T, et al. (2012) A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 22: 436-445.
28. Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, et al. (2007) KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res 13: 3229-3234.
29. Yuan S, Yu SL, Chen HY, Hsu YC, Su KY, et al. (2011) Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations. J Clin Oncol 29: 3435-3442.
30. Robbins SL, Kumar V, Cotran RS (2010) Robbins and Cotran pathologic basis of disease. Philadelphia, PA: Saunders/Elsevier. xiv, 1450 p.
31. Hamburger AW, Salmon SE, (1977) Primary bioassay of human tumor stem cells. Science 197: 461-463.
32. Fisher PB, Dorsch-Hasler K, Weinstein IB, Ginsberg HS, (1979) Tumour promoters enhance anchorage-independent growth of adenovirus-transformed cells without altering the integration pattern of viral sequences. Nature 281: 591-594.
33. Cavallaro U, Christofori G, (2001) Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 1552: 39-45.
34. Carmona FJ, Villanueva A, Vidal A, Munoz C, Puertas S, et al. (2012) Epigenetic disruption of cadherin-11 in human cancer metastasis. J Pathol.
35. Shih LM, Hsu MY, Palazzo JP, Herlyn M, (1997) The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Am J Pathol 151: 745-751.
36. Chan JY, (2011) A clinical overview of centrosome amplification in human cancers. Int J Biol Sci 7: 1122-1144.
37. Bakhoum SF, Compton DA, (2012) Chromosomal instability and cancer: a complex relationship with therapeutic potential. J Clin Invest 122: 1138-1143.
38. McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C, (2012) Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep 13: 528-538.
39. Pfau SJ, Amon A, (2012) Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep 13: 515-527.
40. Lengauer C, Kinzler KW, Vogelstein B, (1997) Genetic instability in colorectal cancers. Nature 386: 623-627.
41. Thompson SL, Bakhoum SF, Compton DA, (2010) Mechanisms of chromosomal instability. Curr Biol 20: R285-295.
42. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, et al. (2005) Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437: 1043-1047.
43. Abiatari I, DeOliveira T, Kerkadze V, Schwager C, Esposito I, et al. (2009) Consensus transcriptome signature of perineural invasion in pancreatic carcinoma. Mol Cancer Ther 8: 1494-1504.
44. Demokan S, Chang X, Chuang A, Mydlarz WK, Kaur J, et al. (2010) KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer 127: 2351-2359.
45. Alonso ME, Bello MJ, Arjona D, Gonzalez-Gomez P, Aminoso C, et al. (2005) Mutational study of the 1p located genes p18ink4c, Patched-2, RIZ1 and KIF1B in oligodendrogliomas. Oncol Rep 13: 539-542.
46. Czyzyk-Krzeska MF, Meller J, (2004) von Hippel-Lindau tumor suppressor: not only HIF's executioner. Trends Mol Med 10: 146-149.
47. Ban S, Shinohara T, Hirai Y, Moritaku Y, Cologne JB, et al. (2001) Chromosomal instability in BRCA1- or BRCA2-defective human cancer cells detected by spontaneous micronucleus assay. Mutat Res 474: 15-23.
48. Chambers AF, Groom AC, MacDonald IC, (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572.
49. Steeg PS, (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
50. Nakagawa T, Setou M, Seog D, Ogasawara K, Dohmae N, et al. (2000) A novel motor, KIF13A, transports mannose-6-phosphate receptor to plasma membrane through direct interaction with AP-1 complex. Cell 103: 569-581.
51. Corson TW, Huang A, Tsao MS, Gallie BL, (2005) KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 24: 4741-4753.
52. Wang Q, Wang L, Li D, Deng J, Zhao Z, et al. (2013) Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients. Cancer Epidemiol 37: 79-84.
53. Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, et al. (2008) Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 17: 1363-1372.
54. Theriault BL, Pajovic S, Bernardini MQ, Shaw PA, Gallie BL, (2012) Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer. Int J Cancer 130: 1844-1854.
55. Kim TM, Yim SH, Shin SH, Xu HD, Jung YC, et al. (2008) Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 123: 2808-2815.
56. Zhou W, Christiani DC, (2011) East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer 30: 287-292.
57. Wakefield LM, Roberts AB, (2002) TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
58. Roberts AB, Wakefield LM, (2003) The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A 100: 8621-8623.
59. de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, et al. (2008) Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 22: 449-462.
60. Mountain CF, (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710-1717.
61. Tseng RC, Chang JW, Hsien FJ, Chang YH, Hsiao CF, et al. (2005) Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer 117: 241-247.
62. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, et al. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17: 353-360.
63. Pan SH, Chao YC, Hung PF, Chen HY, Yang SC, et al. (2011) The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1. J Clin Invest 121: 3189-3205.